LOL, I thought the same thing! :) They do seem to have a business model that is poised for success, but the OTC standard business model is to tease and dilute. Hard for OTC management teams to let go of a time-honored strategy that ensures they get paid regardless of what happens to us shareholders.
News 
Market Data 
Discover 
AI
